vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume → Does this make you sick? (From Allegiance Gold) (Ad) Free VTVT Stock Alerts $27.90 +0.02 (+0.07%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media vTv Therapeutics Short Interest DataCurrent Short Volume26,600 sharesPrevious Short Volume28,800 sharesChange Vs. Previous Month-7.64%Dollar Volume Sold Short$742,140.00Short Interest Ratio / Days to Cover0.4Last Record DateApril 30, 2024Outstanding Shares3,010,000 sharesFloat Size837,000 sharesShort Percent of Float3.18%Today's Trading Volume6,600 sharesAverage Trading Volume51,503 sharesToday's Volume Vs. Average13% Short Selling vTv Therapeutics ? Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVTVT Short Interest Over TimeVTVT Days to Cover Over TimeVTVT Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry vTv Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202426,600 shares $742,140.00 -7.6%3.2%0.4 $27.90 4/15/202428,800 shares $720,000.00 -10.6%3.4%0.4 $25.00 3/31/202432,200 shares $757,666.00 -43.7%6.1%0.4 $23.53 3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00 2/29/202438,000 shares $666,900.00 -12.0%8.4%0.5 $17.55 2/15/202443,200 shares $415,152.00 -39.1%6.5%1.4 $9.61 Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202470,900 shares $596,269.00 +78.6%10.7%2.2 $8.41 1/15/202439,700 shares $363,255.00 -20.8%6.0%1.5 $9.15 12/31/202350,100 shares $576,150.00 +27.8%N/A2.3 $11.50 12/15/202339,200 shares $343,000.00 +10.4%5.9%2 $8.75 11/30/202335,500 shares $507,295.00 +25.0%5.3%2.1 $14.29 11/15/202328,400 shares $398,736.00 -97.6%4.3%7.7 $14.04 10/31/20231,180,000 shares $484,980.00 -6.4%4.4%7.1 $0.41 10/15/20231,260,000 shares $587,286.00 +4.1%4.7%7.1 $0.47 9/30/20231,210,000 shares $578,380.00 -4.0%4.5%6.7 $0.48 9/15/20231,260,000 shares $560,826.00 +4.1%4.6%7.6 $0.45 8/31/20231,210,000 shares $617,100.00 -13.6%4.4%5.8 $0.51 8/15/20231,400,000 shares $998,760.00 +15.7%5.1%6.2 $0.71 7/31/20231,210,000 shares $817,960.00 -4.7%4.4%8.5 $0.68 7/15/20231,270,000 shares $915,670.00 -1.6%4.6%9.8 $0.72 6/30/20231,290,000 shares $954,342.00 +7.5%4.7%10.2 $0.74 6/15/20231,200,000 shares $911,880.00 -3.2%4.4%9.6 $0.76 5/31/20231,240,000 shares $979,600.00 +6.9%4.5%15.1 $0.79 5/15/20231,160,000 shares $996,208.00 -1.7%4.2%12.6 $0.86 4/30/20231,180,000 shares $908,600.00 -0.8%4.3%13.4 $0.77 4/15/20231,190,000 shares $880,838.00 -0.8%4.4%13.6 $0.74 3/31/20231,200,000 shares $969,360.00 -1.6%4.4%12.2 $0.81 3/15/20231,220,000 shares $964,044.00 +8.9%4.5%11.5 $0.79 2/28/20231,120,000 shares $907,200.00 No Change4.1%10.3 $0.81 2/15/20231,120,000 shares $985,600.00 -4.3%4.1%17.3 $0.88 1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95 1/15/20231,130,000 shares $921,967.00 -4.2%4.1%16.4 $0.82 12/30/20221,180,000 shares $782,104.00 +8.3%4.3%17.9 $0.66 12/15/20221,090,000 shares $775,971.00 +2.8%4.0%18.1 $0.71 11/30/20221,060,000 shares $873,864.00 -1.9%3.9%15.5 $0.82 11/15/20221,080,000 shares $950,508.00 -3.6%4.0%15.2 $0.88 10/31/20221,120,000 shares $967,680.00 No Change4.1%10.2 $0.86 10/15/20221,120,000 shares $958,048.00 -8.2%4.1%6.3 $0.86 9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97 9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15Bad week to own stocks - see this (Ad)The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. VTVT Short Interest - Frequently Asked Questions What is vTv Therapeutics' current short interest? Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 26,600 shares of VTVT short. 3.18% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest. What is a good short interest percentage for vTv Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.18% of vTv Therapeutics' floating shares are currently sold short. Is vTv Therapeutics' short interest increasing or decreasing? vTv Therapeutics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 26,600 shares, a drop of 7.6% from the previous total of 28,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is vTv Therapeutics' float size? vTv Therapeutics currently has issued a total of 3,010,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 837,000 shares. How does vTv Therapeutics' short interest compare to its competitors? 3.18% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to vTv Therapeutics: Assembly Biosciences, Inc. (0.68%), SELLAS Life Sciences Group, Inc. (12.10%), Affimed (1.54%), Rallybio Co. (9.67%), Cue Biopharma, Inc. (10.20%), Jaguar Health, Inc. (5.19%), Hookipa Pharma Inc (0.91%), Tempest Therapeutics, Inc. (9.42%), SCYNEXIS, Inc. (2.58%), BioXcel Therapeutics, Inc. (4.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short vTv Therapeutics stock? Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against vTv Therapeutics? A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further. How often is vTv Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Assembly Biosciences Short Interest SELLAS Life Sciences Group Short Interest Affimed Short Interest Rallybio Short Interest Cue Biopharma Short Interest Jaguar Health Short Interest Hookipa Pharma Short Interest Tempest Therapeutics Short Interest SCYNEXIS Short Interest BioXcel Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTVT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club